Vivo Bio Tech Limited (VIVOBIOT.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-1176.5%

-₹150.60

vs ₹13.99 price

Levered DCF

-₹110.95

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

—

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-25.67×	7.38×	26.28×	18.82×	21.47×	7.92×	9.71×	15.44×
P/B	0.47×	0.62×	1.22×	0.96×	1×	1.06×	1.31×	1.28×
P/S	0.82×	1.03×	1.46×	0.95×	0.92×	0.87×	0.78×	0.62×
EV / EBITDA	5.12×	3.98×	6.53×	5.15×	7.1×	4.21×	5.43×	5.87×
Gross margin	33.9%	87.6%	91.5%	87.0%	77.7%	86.1%	84.5%	78.9%
Operating margin	20.3%	24.6%	26.4%	24.1%	17.0%	23.5%	28.0%	20.0%
Net margin	-3.2%	15.6%	5.6%	5.1%	4.3%	11.0%	8.0%	4.0%
Current ratio	0.94×	1.51×	1.25×	1.27×	1.12×	1.24×	1.31×	1.33×
Debt / equity	0.72×	0.69×	1.34×	1.2×	1.43×	0.73×	0.74×	0.79×
Interest coverage	1.85×	1.53×	1.51×	1.64×	2.05×	3.32×	5.52×	4.23×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-1.8%	9.3%	4.6%	5.1%	4.7%	13.4%	13.4%	8.2%
Return on invested capital	-2.3%	7.1%	5.7%	6.1%	3.7%	10.9%	26.8%	22.7%
Return on assets	-1.0%	5.1%	1.8%	2.2%	1.8%	7.1%	7.0%	4.1%
Free cash flow yield	-15.0%	-21.7%	11.4%	21.7%	-72.9%	-19.2%	-3.8%	-12.4%
Earnings yield	-3.9%	15.2%	3.8%	5.3%	4.7%	12.6%	10.3%	6.5%
Enterprise value	₹1.1B	₹1B	₹1.4B	₹1.1B	₹1.1B	₹747.5M	₹664.6M	₹558.9M
Net debt / EBITDA	3.07×	2.08×	3.39×	2.83×	4.13×	1.68×	1.91×	2.22×
Cash conversion cycle (days)	145	517	1,015	508	330	602	357	237